Ernica Clinical Consensus Statements on Total Colonic and Intestinal Aganglionosis
Topic overview
This consensus statement from ERNICA addresses surgical and long-term management strategies for total colonic and intestinal aganglionosis, rare and severe variants of Hirschsprung disease affecting less than 10% of patients. The document provides clinical guidance on surgical approaches, management of bowel dysfunction, and ongoing care for these life-threatening congenital conditions.
Key takeaways
- Total colonic aganglionosis (TCA) and total intestinal aganglionosis (TIA) affect <10% of Hirschsprung patients but are life-threatening.
- TCA involves absent ganglion cells throughout the colon; TIA extends into variable lengths of small bowel.
- ERNICA consensus addresses surgical treatment strategies for both TCA and TIA as distinct clinical entities.
- Management of poor bowel function post-operatively is a critical focus area requiring specialized protocols.
- Long-term follow-up protocols are essential for TCA/TIA patients due to ongoing functional challenges.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Ernica Clinical Consensus Statements on Total Colonic and Intestinal Aganglionosis. GlobalCastMD Medical Library. 2024-04-26. https://dev.library.globalcastmd.com/article/8549?via_space=staycurrentmd
Comments